QuadMedicine (464490) Financial Statements

Income Statement

YearRevenueOp ProfitNet IncomeSource
2025-6.4 billion KRW-6.9 billion KRW[source]
2024-4.4 billion KRW-5.0 billion KRW[source]
2023-9.5 billion KRW-9.8 billion KRW
2022-5.1 billion KRW-8.9 billion KRW

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
202550.3 billion KRW20.4 billion KRW29.9 billion KRW[source]
202431.9 billion KRW20.4 billion KRW11.5 billion KRW[source]
2023
2022

Cash Flow

YearOperatingInvestingFinancingSource
2025-4.5 billion KRW-4.3 billion KRW25.4 billion KRW[source]
20241.1 billion KRW-3.4 billion KRW8.1 billion KRW[source]
2023
2022

This company has no revenue account in the DART financial statements. Industry-specific accounts such as insurance or interest income are not converted to revenue.

Years without a source link are outside the DART financial API collection period.

Cash flow figures for the relevant year were not collected.